Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr. Bronner’s v. organic “cheaters”

This article was originally published in The Rose Sheet

Executive Summary

Defendants including Hain Celestial (Jason, Avalon), Kiss My Face, Giovanni and French certifier Ecocert will be asked to explain "precisely what the term 'organic' means to them as they use it in their branding and marketing" as case moves into discovery phase, Dr. Bronner's Magic Soaps indicates in a March 6 release. Bronner's says it prevailed in February over defendants' final motions to dismiss on grounds that California's Unfair Competition Law is inapplicable in the branding dispute; the San Francisco Superior Court thought otherwise. The plaintiff maintains that products labeled as "Organic" that contain cleansing and moisturizing ingredients made from conventional agricultural and/or petrochemical material unfairly take business from "true" organic brands. Moreover, such products mislead consumers who do not expect alleged organic products to be "simply conventional formulations with some organic tea on top," the soap maker says. In the same release, Bronner's embraces NSF International's recently launched standard for "Made with Organic" personal care, which it calls "a responsible compromise between organic consumers and the cosmetic industry" that was developed with balanced stakeholder participation and "should become entrenched in the marketplace against competing permissive industry standards" (1"The Rose Sheet" Feb. 23, 2009, p. 5). The group behind the draft Organic and Sustainable Industry Standards (OASIS) also is implicated in the suit, but is pursuing an appeal, Bronner's notes

You may also be interested in...



Certifiers In U.S., EU Working On Mutual Recognition Of “Made With Organic”

With the launch of NSF International's "Made with Organic" standard for personal-care products, certifiers have teamed up to facilitate companies' compliance with "like" requirements on either side of the Atlantic

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016004

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel